Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Characterisation of a Novel Anti-CD52 Antibody with Improved Efficacy and Reduced Immunogenicity.
Neurosarcoidosis.
The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis.
Myelin proteomics: the past, the unexpected and the future.
Treatment with the Immunomodulator FTY720 (Fingolimod) Significantly Reduces Renal Inflammation in Murine Unilateral Ureteral Obstruction.
Janus Faces of Amyloid Proteins in Neuroinflammation.
Neuroinflammation. Contemporary anti-inflammatory treatment approaches.
T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved.
Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system.
Calcium-phosphate metabolism in patients with multiple sclerosis.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720).
[Optic neuritis after influenza vaccination in a patient after stem cell transplantation].
Astrogliopathy and oligodendrogliopathy are early events in CNS demyelination.
Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples.
Segmented corpus callosum diffusivity correlates with the Expanded Disability Status Scale score in the early stages of relapsing-remitting multiple sclerosis.
New Strategies in the Management of Guillain-Barré Syndrome.
Environmental factors acting during development to influence MS risk: insights from animal studies.
Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging.
Neuroimaging biomarkers of neurodegenerative diseases and dementia.
Organic Causes of Erectile Dysfunction in Men Under 40.
RORγt Expression and Lymphoid Neogenesis in the Brain of Patients with Secondary Progressive Multiple Sclerosis.
[Progressive multifocal leukoencephalopathy (review)].
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.
Pages
« first
‹ previous
…
429
430
431
432
433
434
435
436
437
…
next ›
last »